Eurofins secondary issue to weather Neuer Markt storm
The Eu40m-Eu46m secondary listing of pharmacological analysis company Eurofins Scientific may be the only survivor of a turbulent week on the Neuer
Markt when it closes today.
The Nouveau Marché listed company is offering 1.155m shares at Eu35-Eu40 and has already had strong demand. WestLB is lead manager
...
Please take a trial or subscribe to access this content.
Contact our subscriptions team to discuss your access: subs@globalcapital.com
Or sign up for a trial to gain full access to the entire site for a limited period.
Corporate access
To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: subs@globalcapital.com or find out more online here.
